GSK Wants to Replace Drugs with Tiny Implants

“GlaxoSmithKline (GSK) has developed a division devoted entirely to bioelectronics that can be attached to nerves to regulate drugs, or even eliminate the need for them.  GSK is seen as a pioneer in this space, and is partially funding development of...

A Blueprint for More U.S. Early Feasibility Studies

According to MDDIonline.com, “A public-private partnership has put forth a draft blueprint intended to give medical device companies a helping hand in planning and conducting early feasibility studies (EFS) in the United States.  Ensuring that medical device...

Medtronic Boasts Positive Results for Self-Expanding Stent

After a three-year trial, Medtronic is touting positive results for the EverFlex self-expanding stent for treating peripheral artery disease it acquired when it bought Covidien for $50 billion, according to MassDevice.com.  “The global medical device giant said...